The Psoriasis Pipeline: Upcoming New Systemic Drugs | Andrew Blauvelt, MD, MBA | United States

Through concise, timely, and relevant presentations, International Psoriasis Council's global leaders in psoriasis share their expert insight, the latest research, and practical information designed to improve the care of psoriasis patients around the world.

In this course, Andrew Blauvelt presents information about new systemic drugs being developed for psoriasis.